Cargando…
Personalized radioiodine therapy for thyroid cancer patients with known disease
Radioactive iodine (RAI) (131)I is a targeted therapy for patients with RAI-avid follicular cell-derived thyroid cancer. However, the responsiveness to (131)I therapy varies among thyroid cancer patients mainly owing to differential RAI uptake and RAI radiosensitivity among patients’ lesions. A pers...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103907/ https://www.ncbi.nlm.nih.gov/pubmed/33977289 http://dx.doi.org/10.12703/r/10-36 |
_version_ | 1783689385139503104 |
---|---|
author | Jhiang, Sissy M Cheng, Peng Nabhan, Fadi A Sipos, Jennifer A Menq, Chia-Hsiang |
author_facet | Jhiang, Sissy M Cheng, Peng Nabhan, Fadi A Sipos, Jennifer A Menq, Chia-Hsiang |
author_sort | Jhiang, Sissy M |
collection | PubMed |
description | Radioactive iodine (RAI) (131)I is a targeted therapy for patients with RAI-avid follicular cell-derived thyroid cancer. However, the responsiveness to (131)I therapy varies among thyroid cancer patients mainly owing to differential RAI uptake and RAI radiosensitivity among patients’ lesions. A personalized approach to maximize (131)I therapeutic efficacy is proposed based on recent scientific advances and future opportunities. |
format | Online Article Text |
id | pubmed-8103907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Faculty Opinions Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-81039072021-05-10 Personalized radioiodine therapy for thyroid cancer patients with known disease Jhiang, Sissy M Cheng, Peng Nabhan, Fadi A Sipos, Jennifer A Menq, Chia-Hsiang Fac Rev Review Article Radioactive iodine (RAI) (131)I is a targeted therapy for patients with RAI-avid follicular cell-derived thyroid cancer. However, the responsiveness to (131)I therapy varies among thyroid cancer patients mainly owing to differential RAI uptake and RAI radiosensitivity among patients’ lesions. A personalized approach to maximize (131)I therapeutic efficacy is proposed based on recent scientific advances and future opportunities. Faculty Opinions Ltd 2021-04-07 /pmc/articles/PMC8103907/ /pubmed/33977289 http://dx.doi.org/10.12703/r/10-36 Text en Copyright: © 2021 Jhiang SM et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Jhiang, Sissy M Cheng, Peng Nabhan, Fadi A Sipos, Jennifer A Menq, Chia-Hsiang Personalized radioiodine therapy for thyroid cancer patients with known disease |
title | Personalized radioiodine therapy for thyroid cancer patients with known disease |
title_full | Personalized radioiodine therapy for thyroid cancer patients with known disease |
title_fullStr | Personalized radioiodine therapy for thyroid cancer patients with known disease |
title_full_unstemmed | Personalized radioiodine therapy for thyroid cancer patients with known disease |
title_short | Personalized radioiodine therapy for thyroid cancer patients with known disease |
title_sort | personalized radioiodine therapy for thyroid cancer patients with known disease |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103907/ https://www.ncbi.nlm.nih.gov/pubmed/33977289 http://dx.doi.org/10.12703/r/10-36 |
work_keys_str_mv | AT jhiangsissym personalizedradioiodinetherapyforthyroidcancerpatientswithknowndisease AT chengpeng personalizedradioiodinetherapyforthyroidcancerpatientswithknowndisease AT nabhanfadia personalizedradioiodinetherapyforthyroidcancerpatientswithknowndisease AT siposjennifera personalizedradioiodinetherapyforthyroidcancerpatientswithknowndisease AT menqchiahsiang personalizedradioiodinetherapyforthyroidcancerpatientswithknowndisease |